Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Real-World Outcomes of Bendamustine & Rituximab With or Without Maintenance Rituximab in Follicular Lymphoma: A TriNetX Analysis

IBCL - 1764

Real-World Outcomes of Bendamustine & Rituximab With or Without Maintenance Rituximab in Follicular Lymphoma: A TriNetX Analysis

Anuja Abhyankar

Poster Presenter: Anuja Abhyankar

Thumbnail for Real-World Outcomes of CD19 CAR T-Cell Therapies in Follicular Lymphoma: A Comparative Analysis of Axicabtagene Ciloleucel, Lisocabtagene Maraleucel, and Tisagenlecleucel

CT - 1766

Real-World Outcomes of CD19 CAR T-Cell Therapies in Follicular Lymphoma: A Comparative Analysis of Axicabtagene Ciloleucel, Lisocabtagene Maraleucel, and Tisagenlecleucel

Sangam Sangam

Poster Presenter: Sangam Sangam

Thumbnail for Real-World Outcomes of Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A National Multicenter Retrospective Cohort Study

ABCL - 1431

Real-World Outcomes of Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A National Multicenter Retrospective Cohort Study

Saurav Das

Poster Presenter: Saurav Das

Thumbnail for Real-World Outcomes of Diffuse Large B-Cell Lymphoma: A 7-Year Retrospective Cohort Study from a Tertiary Care Center in a Low- and Middle-Income Country

ABCL - 286

Real-World Outcomes of Diffuse Large B-Cell Lymphoma: A 7-Year Retrospective Cohort Study from a Tertiary Care Center in a Low- and Middle-Income Country

Shahzeb Ahmed

Poster Presenter: Shahzeb Ahmed

Thumbnail for Real-World Outcomes of Dose-Modified Polatuzumab Vedotin-R-CHP in Older Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Retrospective Study From Northern India

ABCL - 666

Real-World Outcomes of Dose-Modified Polatuzumab Vedotin-R-CHP in Older Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Retrospective Study From Northern India

Ajay Gogia

Poster Presenter: Ajay Gogia

Thumbnail for Real-World Outcomes of Imetelstat: Interrogating Safety, Efficacy, and Predictors of Response in Heavily Pretreated Lower-Risk Patients With MDS

MDS - 646

Real-World Outcomes of Imetelstat: Interrogating Safety, Efficacy, and Predictors of Response in Heavily Pretreated Lower-Risk Patients With MDS

Rami Komrokji

Poster Presenter: Rami Komrokji

$Thumbnail for Real-World Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma$

MCL - 906

Real-World Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma

Sally Jones*

Poster Presenter: Sally Jones*

Thumbnail for Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

CLL - 916

Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Real-World Outcomes of Primary and Secondary Plasma Cell Leukemia in the Era of CAR-T and Bispecific Antibody Therapy: A Single-Center Experience

MM - 1031

Real-World Outcomes of Primary and Secondary Plasma Cell Leukemia in the Era of CAR-T and Bispecific Antibody Therapy: A Single-Center Experience

Abat Khan

Poster Presenter: Abat Khan

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.